Select Medical (SEM) | Financial Analysis & Statements
Select Medical Holdings Corp. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.4B
Gross Profit
145.8M
10.44%
Operating Income
63.9M
4.58%
Net Income
37.7M
2.70%
EPS (Diluted)
$0.16
Balance Sheet Metrics
Total Assets
5.9B
Total Liabilities
3.8B
Shareholders Equity
2.0B
Debt to Equity
1.87
Cash Flow Metrics
Operating Cash Flow
36.1M
Free Cash Flow
5.2M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Select Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 5.5B | 5.2B | 6.7B | 6.3B | 6.2B |
| Cost of Goods Sold | 4.8B | 4.6B | 5.7B | 5.6B | 5.3B |
| Gross Profit | 629.3M | 633.6M | 932.0M | 733.4M | 919.4M |
| Gross Margin % | 11.5% | 12.2% | 14.0% | 11.6% | 14.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 154.4M | 225.9M | 170.2M | 153.0M | 147.0M |
| Other Operating Expenses | -1.6M | -3.4M | -1.8M | -28.8M | -144.0M |
| Total Operating Expenses | 152.8M | 222.5M | 168.4M | 124.3M | 2.9M |
| Operating Income | 336.2M | 268.3M | 554.9M | 403.3M | 713.8M |
| Operating Margin % | 6.2% | 5.2% | 8.3% | 6.4% | 11.5% |
| Non-Operating Items | |||||
| Interest Income | - | - | 0 | 0 | 5.4M |
| Interest Expense | 117.9M | 128.6M | 198.6M | 169.1M | 136.0M |
| Other Non-Operating Income | 54.5M | 35.1M | 26.1M | 26.4M | 46.6M |
| Pre-tax Income | 272.7M | 174.8M | 382.4M | 260.6M | 629.7M |
| Income Tax | 58.2M | 44.8M | 82.6M | 62.6M | 129.8M |
| Effective Tax Rate % | 21.3% | 25.6% | 21.6% | 24.0% | 20.6% |
| Net Income | 214.5M | 296.7M | 299.7M | 198.0M | 499.9M |
| Net Margin % | 3.9% | 5.7% | 4.5% | 3.1% | 8.1% |
| Key Metrics | |||||
| EBITDA | 531.0M | 536.1M | 804.4M | 635.5M | 966.2M |
| EPS (Basic) | - | $1.66 | $1.91 | $1.23 | $2.98 |
| EPS (Diluted) | - | $1.66 | $1.91 | $1.23 | $2.98 |
| Basic Shares Outstanding | - | 124614000 | 123105000 | 122511000 | 130249000 |
| Diluted Shares Outstanding | - | 124614000 | 123105000 | 122511000 | 130249000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Select Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 26.5M | 59.7M | 84.0M | 97.9M | 74.3M |
| Short-term Investments | - | 0 | 59.0M | 74.9M | 0 |
| Accounts Receivable | 864.2M | 821.4M | 940.3M | 941.3M | 889.3M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 114.9M | 112.1M | 151.6M | 125.4M | 120.2M |
| Total Current Assets | 1.0B | 1.0B | 1.3B | 1.3B | 1.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 957.9M | 908.1M | 1.2B | 1.2B | 1.1B |
| Goodwill | 4.8B | 4.8B | 7.4B | 7.3B | 7.3B |
| Intangible Assets | 100.8M | 103.2M | 329.9M | 351.7M | 374.9M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 414.4M | 372.8M | 376.7M | 341.7M | 338.7M |
| Total Non-Current Assets | 4.8B | 4.6B | 6.4B | 6.4B | 6.2B |
| Total Assets | 5.9B | 5.6B | 7.7B | 7.7B | 7.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 157.1M | 142.2M | 174.3M | 186.7M | 233.8M |
| Short-term Debt | 229.4M | 225.7M | 346.0M | 313.1M | 289.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 984.5M | 977.7M | 1.2B | 1.2B | 1.3B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.6B | 2.5B | 4.6B | 4.8B | 4.5B |
| Deferred Tax Liabilities | 112.2M | 81.5M | 143.3M | 169.8M | 142.8M |
| Other Non-Current Liabilities | 79.9M | 73.0M | 110.3M | 106.1M | 106.4M |
| Total Non-Current Liabilities | 2.8B | 2.6B | 4.9B | 5.1B | 4.7B |
| Total Liabilities | 3.8B | 3.6B | 6.1B | 6.3B | 6.0B |
| Equity | |||||
| Common Stock | 124.0K | 129.0K | 128.0K | 127.0K | 134.0K |
| Retained Earnings | 837.0M | 770.1M | 751.9M | 581.0M | 593.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.0B | 2.0B | 1.6B | 1.4B | 1.4B |
| Key Metrics | |||||
| Total Debt | 2.9B | 2.7B | 5.0B | 5.2B | 4.8B |
| Working Capital | 40.8M | 42.1M | 9.2M | 116.2M | -133.6M |
Balance Sheet Composition
Select Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 214.5M | 296.7M | 299.7M | 198.0M | 499.9M |
| Depreciation & Amortization | 140.3M | 203.9M | 208.7M | 205.8M | 202.6M |
| Stock-Based Compensation | 16.7M | 100.7M | 43.8M | 37.8M | 30.9M |
| Working Capital Changes | -54.4M | -81.6M | -24.6M | -172.4M | -256.8M |
| Operating Cash Flow | 350.9M | 490.2M | 514.2M | 279.0M | 484.0M |
| Investing Activities | |||||
| Capital Expenditures | -229.2M | -222.2M | -229.2M | -190.4M | -180.5M |
| Acquisitions | -10.7M | -13.1M | -39.4M | -44.3M | -102.9M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -216.5M | -231.0M | -268.5M | -226.3M | -256.6M |
| Financing Activities | |||||
| Share Repurchases | -100.1M | -37.9M | -12.8M | -195.5M | -79.5M |
| Dividends Paid | -31.4M | -64.6M | -63.9M | -64.6M | -50.6M |
| Debt Issuance | 1.4B | 4.3B | 3.0B | 1.1B | 193.0M |
| Debt Repayment | -1.3B | -4.8B | -3.2B | -881.0M | -39.7M |
| Financing Cash Flow | -172.2M | -315.6M | -329.2M | -45.3M | -647.4M |
| Free Cash Flow | 117.2M | 295.7M | 352.9M | 94.5M | 220.7M |
| Net Change in Cash | -37.8M | -56.5M | -83.4M | 7.4M | -420.0M |
Cash Flow Trend
Select Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
14.15
Forward P/E
11.66
Price to Book
1.19
Price to Sales
0.37
PEG Ratio
-0.06
Profitability Ratios
Profit Margin
2.68%
Operating Margin
4.58%
Return on Equity
10.64%
Return on Assets
3.67%
Financial Health
Current Ratio
1.04
Debt to Equity
140.92
Beta
0.88
Per Share Data
EPS (TTM)
$1.16
Book Value per Share
$13.75
Revenue per Share
$44.46
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SEM | 2.0B | 14.15 | 1.19 | 10.64% | 2.68% | 140.92 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Pacs | 5.5B | 28.73 | 5.80 | 22.96% | 3.62% | 377.77 |
| Chemed | 5.6B | 20.88 | 5.36 | 25.28% | 10.48% | 14.68 |
| Option Care Health | 4.5B | 22.35 | 3.36 | 15.20% | 3.67% | 96.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.





